Use of estramustine phosphate in the treatment of bone metastases and in the treatment of bone metastases in patients with Prostate Cancer

• 1. 雌莫司汀磷酸盐在治疗骨转移瘤中的用途 [P] . 中国专利： CN1446086A . 2003-10-01
• 2. 雌莫司汀在制备抑制肿瘤细胞转移和扩散的药物中的应用 [P] . 中国专利： CN104606202A . 2015-05-13
• 3. Use of estramustine phosphate in the treatment of bone metastases [P] . 日本专利： JP2004504346A . 2004-02-12

  机译： 磷酸雌莫司汀在骨转移治疗中的应用

• 4. Use of estramustine phosphate in the treatment of bone metastases [P] . PE03012002A1 . 2002-04-07

  机译： 磷酸雌莫司汀在骨转移治疗中的应用

• 5. DUAL INHIBITORS OF MET AND VEGF FOR THE TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER AND OSTEOBLASTIC BONE METASTASES [P] . HUE045810T2 . 2020-01-28

  机译： MET和VEGF的双重抑制剂可治疗抗结直肠癌和成骨细胞转移瘤

• 1. Long-term Efficacy and Safety of Pamidronate Disodium in Treatment of Bone Metastases in Breast Cancer [J] . Li-jun Di, Jun Ren, Ying Yan, 中国癌症研究（英文版） . 2009,第002期
• 2. Tumor-and osteoclast-derived NRP2 in prostate cancer bone metastases [J] . Navatha Shree Polavaram, Brian A.Costello, Raffael Jimenez, 骨研究（英文版） . 2021,第002期
• 3. Tumor-and osteoclast-derived NRP2 in prostate cancer bone metastases [J] . Navatha Shree Polavaram, Samikshan Dutta, Ridwan Islam, 骨研究：英文 . 2021,第002期
• 4. Engineering osteoblastic metastases to delineate the adaptive response of androgen-deprived prostate cancer in the bone metastatic microenvironment [J] . Nathalie Bock, Ali Shokoohmand, Thomas Kryza, 骨研究（英文版） . 2019,第002期
• 5. Characterization of Bone Quality in Prostate Cancer Bone Metastases Using Raman Spectroscopy [C] . Xiaohong Bi, Chetan Patil, Colm Morrissey, Photonic therapeutics and diagnostics VI . 2010
• 6. The role of adrenomedullin in osteolytic breast cancer bone metastases. [D] . Siclari, Valerie Anne. 2009
• 7. Usefulness of bone turnover markers as predictors of mortality risk disease progression and skeletal-related events appearance in patients with prostate cancer with bone metastases following treatment with zoledronic acid: TUGAMO study [O] . C de la Piedra, A Alcaraz, J Bellmunt, 2013
• 8. Bone pain and bone targeting agent (Bta) treatment pattern in patients with bone metastases (Bms) from prostate cancer (Pc) in real world setting in Europe [O] . Body, J, Henry, D, von Moos, R, 2015

• 1. Racial Disparities in Survival Outcomes of Prostate Cancer Patients after Surgery for Bone Metastases [J] . Robert L. Satcher ,Oluwatosin Bamidele ,Patrick Lin . 癌症治疗（英文） . 2013,第4期
• 2. 多西他赛联合雌莫司汀治疗43例抵抗性晚期前列腺癌患者临床疗效观察 [C] . 张永利 ,吴坤 ,谭琨 . 第五届中国中医药信息大会 . 2018
• 3. 肿瘤微环境相关外周血指标对初诊前列腺癌患者骨转移风险的预测价值 [A] . 王志杰 . 2021